Dolores J. Cahill’s research and innovation areas are proteomics, protein arrays, biomarker discovery and validation. She co-founded a Max-Planck-Institute, Berlin spin-out, Protagen AG, a successful German biomedical company (1997 – sold March 2019).
She has advised on Science and Innovation as a Member of Ireland’s Advisory Science Council (2005-2014); as European Commission Seconded National Expert (2013-2014) and an EC expert for over 10 years.
